614 related articles for article (PubMed ID: 26076857)
1. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
2. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
3. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.
Suh-Lailam BB; Haven TR; Copple SS; Knapp D; Jaskowski TD; Tebo AE
Clin Chim Acta; 2013 Jun; 421():1-6. PubMed ID: 23454475
[TBL] [Abstract][Full Text] [Related]
4. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Chen C; Chen Y; Xu Y; Chang Y; Li R; Sun X; Peng L; Lu Z; Qiu W
Eur J Neurol; 2018 Jan; 25(1):178-184. PubMed ID: 29053906
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
7. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
9. Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Zhao J; Wang C; Zhang Y; Sun R; Wang H; Li G; Zhang J
J Neuroimmunol; 2019 Sep; 334():577005. PubMed ID: 31310926
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Wang Y; Lu T; Li R; Sun X; Li J; Chang Y; Hu X; Lu Z; Qiu W
Neurochem Int; 2017 Sep; 108():34-39. PubMed ID: 28192149
[TBL] [Abstract][Full Text] [Related]
11. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
Front Immunol; 2021; 12():680424. PubMed ID: 34220828
[TBL] [Abstract][Full Text] [Related]
12. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
13. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit.
Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X
Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725
[TBL] [Abstract][Full Text] [Related]
14. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
Front Immunol; 2019; 10():905. PubMed ID: 31214158
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
16. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis.
Hümmert MW; Jendretzky KF; Fricke K; Gingele M; Ratuszny D; Möhn N; Trebst C; Skripuletz T; Gingele S; Sühs KW
Sci Rep; 2023 Aug; 13(1):12696. PubMed ID: 37542085
[TBL] [Abstract][Full Text] [Related]
17. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: A hospital-based prospective study.
Ma J; Han W; Jiang L
Brain Dev; 2020 Feb; 42(2):179-184. PubMed ID: 31563418
[TBL] [Abstract][Full Text] [Related]
18. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
19. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
20. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
